The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Print

Oral Session

Oral Session 3-7D Iatrogenic LPD

Sun. Oct 14, 2018 3:00 PM - 4:00 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Yasufumi Masaki (Department of Hematology and Immunology, Japan)

[OS3-7D-1] Clinical outcome of methotrexate-induced lymphoproliferative disorders

Takuya Harada1, Kentaro Kohno2, Masatoshi Shimo1, Kanae Fujii1, Jun Odawara1, Masanori Kadowaki1, Ken Takase1, Satoshi Yamasaki1, Morishige Takeshita3, Hiromi Iwasaki1 (1.Department of Hematology, National Hospital Organization Kyushu Medical Center., 2.Department of Hematology and Oncology, JCHO Kyushu Hospital, 3.Department of Pathology, Fukuoka University School of Medicine)

[OS3-7D-2] Clinicopathological analysis of LPD that developed in RA patients receiving calcineurin inhibitors

Yoshihiko Hoshida1, Shiro Oshima2, Yukihiko Saeki2, Tomonori Kawasaki3, Syu Ichihara3, Atsushi Kaneko4, Masao Katayama5, Kazuo Kuraoka6, Michiko Kida7, Ikuo Saito8, Shigeto Tohma9, Mitsutoshi Kurosawa10, Hiroyuki Sugahara11, Yasushi Hiramatsu12, Hiroki Yabe13 (1.Pathology, Osaka Minami Medical Center, Kawachinagano, Japan, 2.Rheumatology, Osaka Minami Medical Center, Kawachinagano, Japan, 3.Pathology, Nagoya Medical Center, Nagoya, Japan, 4.Orthopedics, Nagoya Medical Center, Nagoya, Japan, 5.Rheumatology, Nagoya Medical Center, Nagoya, Japan, 6.Pathology, Kure Medical Center, Kure, Japan, 7.Hematology, Kure Medical Center, Kure, Japan, 8.Pathology, Sagamihara Hospital, Sagamihara, Japan, 9.Rheumatology, Tokyo Hospital, Tokyo, Japan, 10.Hematology, Hokkaido Cancer Center, Sapporo, Japan, 11.Hematology, Sumitomo Hospital, Osaka, Japan, 12.Hematology, HImeji Red Cross Hospital, Himeji, Japan, 13.Hematology, Ako Central Hospital, Ako, Japan)